Search by Drug Name or NDC

    NDC 00075-8014-10 Lovenox 40 mg/.4mL Details

    Lovenox 40 mg/.4mL

    Lovenox is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is ENOXAPARIN SODIUM.

    Product Information

    NDC 00075-8014
    Product ID 0075-8014_5651b020-2238-46af-9068-dd3b2795928d
    Associated GPIs 8310102010E525
    GCN Sequence Number 039482
    GCN Sequence Number Description enoxaparin sodium SYRINGE 40MG/0.4ML SUBCUT
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 70022
    HICL Sequence Number 007878
    HICL Sequence Number Description ENOXAPARIN SODIUM
    Brand/Generic Brand
    Proprietary Name Lovenox
    Proprietary Name Suffix n/a
    Non-Proprietary Name enoxaparin sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 40
    Active Ingredient Units mg/.4mL
    Substance Name ENOXAPARIN SODIUM
    Labeler Name Sanofi-Aventis U.S. LLC
    Pharmaceutical Class Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020164
    Listing Certified Through 2024-12-31

    Package

    NDC 00075-8014-10 (00075801410)

    NDC Package Code 0075-8014-10
    Billing NDC 00075801410
    Package 10 CELLO PACK in 1 CARTON (0075-8014-10) / 1 SYRINGE in 1 CELLO PACK / .4 mL in 1 SYRINGE (0075-8014-01)
    Marketing Start Date 1993-03-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL de6fb917-a94a-41ea-9d7d-937d4080ffcd Details

    Revised: 4/2022